期刊
NEUROTHERAPEUTICS
卷 4, 期 2, 页码 305-314出版社
SPRINGER
DOI: 10.1016/j.nurt.2007.01.007
关键词
autoantibodies; antigenic modulation; neuromuscular junction; thymoma; lung cancer; pyridostigmine
资金
- NINDS NIH HHS [R01NS48077, P50NS32353] Funding Source: Medline
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048077, N01NS032353] Funding Source: NIH RePORTER
Thirty years ago, antibodies against the muscle acetylcholine receptor (AChR) were recognized as the cause of myasthenia gravis. Since then, there has been great interest in identifying other neurological disorders associated with autoantibodies. Several other antibody-mediated neuromuscular disorders have been identified, each associated with an antibody against a ligand- or voltage-gated ion channel. The Lambert-Eaton syndrome is caused by antibodies against voltagegated calcium channels and often occurs in patients with small cell lung cancer. Acquired neuromyotonia is caused by voltagegated potassium channel antibodies, and autoimmune autonomic ganglionopathy is caused by antibodies against the neuronal AChR in autonomic ganglia. There is good evidence that antibodies in these disorders cause changes in synaptic function or neuronal excitability by directly inhibiting ion channel func-tion. More recently, studies have identified ion channel antibodies in patients with certain CNS disorders, such as steroidresponsive encephalitis and paraneoplastic cerebellar ataxia. It remains unclear if antibodies can gain access to the CNS and directly cause ion channel dysfunction. Treatment of autoimmune channelopathies includes drugs that help restore normal neuronal function and treatments to remove pathogenic antibodies (plasma exchange) or modulate the immune response (steroids or immunosuppressants). These disabling neurological disorders may be dramatically responsive to immunomodulatory therapy. Future studies will likely lead to identification of other ion channel antibodies and other autoimmune channelopathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据